News

AIM ImmunoTech Secures New State-of-the-Art Facility for Product Development and Testing

Company enters into a lease agreement with the state-supported New Jersey Bioscience Center at North Brunswick, one of the nation’s…

2 years ago

Acer Therapeutics Announces Promotion of Tanya Hayden to Chief Operating Officer

NEWTON, Mass., June 21, 2022 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition,…

2 years ago

CareView Communications Selected to Exhibit Patient Safety System at Vizient Innovative Technology Exchange

LEWISVILLE, Texas--(BUSINESS WIRE)--CareView Communications, Inc. ("CareView" or the "Company") (OTCQB: CRVW), an information technology provider to the healthcare industry, has…

2 years ago

Imperative Care Appoints Henrietta Fore and Stacy Enxing Seng to Board of Directors

Respected leaders bring deep industry expertise and diverse perspectives to further enable company’s substantial growth CAMPBELL, Calif.--(BUSINESS WIRE)--Imperative Care, Inc.…

2 years ago

Agilent Laboratory Achieves Green Lab Certification

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the company’s customer demonstration laboratory in Waldbronn, Germany has…

2 years ago

More Than 80% of Healthcare Executives Expect the Metaverse Will Have a Positive Impact on Their Organizations, According to a New Accenture Report

Emerging technologies are converging to reshape digital healthcare NEW YORK--(BUSINESS WIRE)--Accenture’s (NYSE: ACN) Digital Health Technology Vision 2022 report found…

2 years ago

Barnes Announces Appointment of Thomas J. Hook as President and Chief Executive Officer; CEO Patrick Dempsey to Become Executive Vice Chairman of Barnes

Board Names Medical Technology CEO and Barnes Director as Company’s New Leader After Dempsey’s Nearly 10 Years as Barnes’ CEO…

2 years ago

Midatech Pharma PLC Announces MTX110 Development for the Treatment of Glioma

Orphan Designation Granted by EMA to MTX110 Development for the Treatment of GliomaABINGDON, NR / ACCESSWIRE / June 21, 2022…

2 years ago

NeoGenomics Liquid Biopsy Subsidiary Inivata Announces New Data Demonstrating Clinical Potential of the RaDaR(TM) MRD Test in HR+ HER2- Breast Cancer

FT. MYERS, FL / ACCESSWIRE / June 21, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing…

2 years ago

Midatech Pharma PLC Announces Directorate Change

ABINGDON, OXFORDSHIRE / ACCESSWIRE / June 20, 2022 / Midatech Pharma PLC (AIM:MTPH.L)(Nasdaq:MTP), an R&D biotechnology company focused on improving…

2 years ago